| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:AA 29504
CAS:945828-50-2
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
| Company Name: |
MedBioPharmaceutical Technology Inc
|
| Tel: |
021-69568360 18916172912 |
| Email: |
order@med-bio.cn |
| Products Intro: |
Product Name:AA 29504
CAS:945828-50-2
Purity:98% Package:10mg; 50mg Remarks:Medbio
|
| Company Name: |
JinOu Biomedical (Nanjing) Co., Ltd.
|
| Tel: |
13000000000 |
| Email: |
jinoupharma@163.com |
| Products Intro: |
Product Name:N1-Ethoxycarbonyl-N4-[(2,4,6-trimethylpheny)lmethyl]-1,2,4-triaminobenzene
CAS:945828-50-2
Purity:99% HPLC Package:100G;1KG;100KG
|
|
| | AA 29504 Basic information |
| Product Name: | AA 29504 | | Synonyms: | AA 29504;N-[2-Amino-4-[[(2,4,6-trimethylphenyl)methyl]amino]phenyl]-carbamic acid-ethyl ester;ethyl N-[2-amino-4-[(2,4,6-trimethylphenyl)methylamino]phenyl]carbamate;N1-Ethoxycarbonyl-N4-[(2,4,6-trimethylpheny)lmethyl]-1,2,4-triaminobenzene;Carbamic acid, N-[2-amino-4-[[(2,4,6-trimethylphenyl)methyl]amino]phenyl]-, ethyl ester | | CAS: | 945828-50-2 | | MF: | C19H25N3O2 | | MW: | 327.42 | | EINECS: | | | Product Categories: | | | Mol File: | 945828-50-2.mol |  |
| | AA 29504 Chemical Properties |
| Boiling point | 469.6±45.0 °C(Predicted) | | density | 1.183±0.06 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: ≥2mg/mL | | form | powder | | pka | 13.13±0.70(Predicted) | | color | white to beige |
| Hazard Codes | Xi | | Risk Statements | 36 | | Safety Statements | 26 | | WGK Germany | 3 |
| | AA 29504 Usage And Synthesis |
| Uses | AA 29504 is used in extrasynaptic GABAA receptor activity activation and has shown to reverse recognition memory deficit in rat models of schizophrenia. | | references | [1]. k. hoestgaard-jensen, n.o. dalby, t.d. wolinsky, et al. pharmacological characterization of a novel positive modulator at α4β3δ-containing extrasynaptic gabaa receptors. neuropharmacology, 2010, 58:702-711.
[2]. trine damgaard, niels plath, jo c. neill, et al. extrasynaptic gabaa receptor activation reverses recognition memory deficits in an animal model of schizophrenia. psychopharmacology, 2011, 214:403-413.
[3]. henrik h. hansen, christina ebbesen, claus mathiesen, et al. the kcnq channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. journal of pharmacology and experimental therapeutics, 2006, 318(3): 1006–1019. |
| | AA 29504 Preparation Products And Raw materials |
|